Many studies have shown that all three pathways of complement activation may be involved in kidney injury in diabetic nephropathy through C1q, C3, and C5 components (i.e., the classic pathway), mannose binding lectin (MBL) activator (i.e., the lectin pathway), and TLR2 and TLR4 (i.e., the alternative pathway), which can increase complement factor B synthesis and release by macrophages. Here, MBL2 is linked to diabetic kidney disease.